LAUREN HOLTZCLAW: Open Payments
NPI 1528665882 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 41 payments from 15 companies in 2025. Trend: 2023 $1,599 · 2024 $1,324 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $287 |
| Merit Medical Systems Inc | 1 | $112 |
| QOL Medical, LLC | 4 | $111 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| GENZYME CORPORATION | 3 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Madrigal Pharmaceuticals | 2 | $39 |
| PFIZER INC. | 2 | $31 |
| Ardelyx, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: DUPIXENT, RINVOQ, ESOPHYX, Sucraid, LINZESS, XIFAXAN, SKYRIZI, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
